TY  - JOUR

T1  - First-line treatment options in metastatic castration-sensitive prostate cancer: A systematic review and network meta-analysis.

JO  - Journal of Clinical Oncology

PY  - 2022/02/20

AU  - Riaz IB

AU  - Naqvi SAA

AU  - Ikram W

AU  - Siddiqi R

AU  - Asghar N

AU  - Khakwani KZR

AU  - Khalid A

AU  - Hussain SA

AU  - Singh P

AU  - Bryce AH

ED  - 

DO  - DOI: 10.1200/jco.2022.40.6_suppl.132

PB  - American Society of Clinical Oncology (ASCO)

VL  - 40

IS  - 6_suppl

SP  - 132

EP  - 132

Y2  - 2024/12/22

ER  -